Trial Profile
Effect of an inhibitor of DPP-IV on glucagon secretion in diabetes type 1 with or without autonomic vegetative neuropathy [Effet d'un inhibiteur de la DPP-IV sur la secretion de glucagon au cours du diabete de type 1 avec ou sans neuropathie autonome vegetative]
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms DPPNAC
- 28 Jan 2013 Planned end date changed from 29 Feb 2012 to 1 Jul 2013 as reported by ClinicalTrials.gov.
- 28 Jun 2012 Planned End Date changed to 29 Feb 2012.
- 28 Jun 2011 New trial record